Latest News
Study Suggests COVID-19 Could Exacerbate CAD
New Cholangiocarcinoma Noncoding RNA Could Become an Intervention Target
Long-Term ERT for Older Adults With LOPD Can Have Variable Results
Barriers Remain in Gene Therapy for Hemophilia Despite Clinical Advancements
Postoperative CA19-9 Shows Prognostic Significance in Cholangiocarcinoma
China’s NMPA Accepts ALGS New Drug Application for Maralixibat
Researchers Emphasize Clinical and Immunohematology Testing for CAD
Conditional Survival Rates Vary Following Intrahepatic Cholangiocarcinoma Surgery
An Interview With Dr. Adrian Krainer From the Cold Spring Harbor Laboratory
Perceived Nusinersen Efficacy May Be Important to Adults With Severe SMA
Psychosocial Factors Associated With Impaired Quality of Life in LCFAOD
Cost-Effectiveness of LAL-D Orphan Drugs Remains Controversial
Coadministration of Cudetaxestat Shows Success in IPF Phase 1 Trial
A Rare Case of VLCAD Deficiency With Severe Concurrent Conditions
Switching to BAY 81-8973 Could Help Optimize Hemophilia Treatment
Newborn Screening May Predict Late-Onset Pompe Disease
Patients With Hemophilia Often Given Potentially Inappropriate Medications
Despite Treatment, Hemarthroses Common in Patients With Severe Hemophilia
Untreated IPF Associated With 50% All-Cause Mortality, Study Finds
Latest Features
-
The Crucial Role of Correct, Timely Diagnosis in the Management of CCA
We explore the importance of correct and timely diagnosis of cholangiocarcinoma (CCA), which can be divided into iCCA, pCCA, and dCCA. -
How Telomere Dysfunction Drives Pathogenesis in IPF
We explore how telomere dysfunction potentially drives the pathogenesis of idiopathic pulmonary fibrosis, and what that could mean for future research. -
The Brains Behind Nusinersen: A Visit With Geneticist Adrian Krainer, PhD
Five years after the approval of nusinersen (Spinraza®) for SMA, Adrian Krainer, PhD, is immensely proud of his role in developing the lifesaving drug. -
Exploring TKI-Induced Nephrotoxicity in Patients With Medullary Thyroid Carcinoma
We explore various issues related to nephrotoxicity induced by tyrosine kinase inhibitors in patients with medullary thyroid carcinoma. -
Genetic Correction Strategies and Their Cardiac Impact in Patients With DMD
We investigate the genetic correction strategies available for DMD patients today and assess their impact on the heart. -
Exploring the Cause and Effect of Endothelial Dysfunction in PAH
Endothelial dysfunction is a prominent feature of pulmonary arterial hypertension. We explore the cause and effects of it. -
The Role of Next-Generation Sequencing in Diagnosing Infants With Cholestasis
We explore the role of next-generation sequencing in providing a genetic diagnosis for infants with a cholestatic disease, such as Alagille syndrome or AATD. -
Comparing First-Line Immunosuppressants Used in NMOSD
We compare the most common types of first-line immunosuppressants currently used to treat neuromyelitis optica spectrum disorder (NMOSD). -
Case Report: CAD Co-occurring With Antiphospholipid Syndrome
We review a case report of a patient who was diagnosed with CAD associated with antiphospholipid syndrome, and explore the role of the complement system.
Latest Patient Perspectives
Older Multiple Sclerosis Patients Deserve More Research
Growing old with multiple sclerosis (MS) comes with its own complications. A disease on top of the normal aging process adds another layer of difficulty.
Should Doctors Steer Rare Disease Patients Away From Starting a Family?
I thought it was normal to want to get married and start a family, but I learned very fast that society doesn’t see that for us rare disease patients.
‘I Try My Best to Not Let Limb-Girdle Muscular Dystrophy Control My Life’
My sister, Jamesha, like me, was diagnosed with limb-girdle muscular dystrophy (LGMD) and was dependent on a BiPap machine and wheelchair.
My Tale of Finding a Mental Health Professional as a DMD Patient
Having a disease like Duchenne muscular dystrophy (DMD) made just searching for a therapist I was comfortable speaking with another quandary.
Rare Care Podcast
Browse Rare Disease Advisor’s engaging “Rare Care” podcast series, featuring interviews with leading researchers, stakeholders, and influencers within the rare disease community.
Latest HCP Insights
What We Know About Efmoroctocog Alfa in Hemophilia A
There has been a number of clinical studies on one of the newer drugs on the market for hemophilia A: efmoroctocog alfa. It has generated excitement among the medical community because it is not a traditional intravenous (IV) replacement therapy; instead, it is a prophylactic medication and has a longer half-life than conventional factor VIII…
Examining the Relationship Between LAL-D and Skeletal Homeostasis
Lysosomal acid lipase deficiency (LAL-D) is a rare disease that results in ectopic lipid accumulation in the body, especially in the liver, spleen, small intestine, blood, and adrenal glands. Given that unesterified cholesterol and fatty acids play an important role in bone metabolism, a team of scientists has proposed that LAL-D also significantly disrupts skeletal…
The Feasibility of Self-Administering AAT Therapy During the COVID-19 Pandemic
The COVID-19 pandemic has been regarded as a litmus test for our modern medical systems. One question it has raised is this: can our modern medical infrastructure cope with a fast-spreading, evasive virus, and do so in accordance with our high modern healthcare standards? There is no use claiming victory if we are only able…
Visualizing Bile Duct Abnormalities in Alagille Syndrome in 3D
A few centuries ago, if a patient complained of general maladies such as “fever” or “chest pain,” the physician could only guess at what was wrong and provide symptomatic relief (such as sponging down the fever and ensuring that the patient is eating and ambulating). We should not be too quick to dismiss the “guesses”…
Clinical Thinking in Diagnosing and Managing Cold Agglutinin Disease
Sigbjørn Berentsen, MD, PhD, is a consultant hematologist and senior researcher in the Department of Research and Innovation at Haugesund Hospital in Norway. He has authored a number of studies on autoimmune hemolytic anemia (AIHA), and its cold agglutinin disease (CAD) subtype. He is a respected expert on the subject in a field in which…
New Insights Into the Management of Carnitine-Acylcarnitine Translocase Deficiency
Carnitine-acylcarnitine translocase deficiency (CACTD) is a type of long chain fatty acid oxidation disorder (LCFAOD) characterized by severe cardiac dysfunction. It has the highest rate of cardiac arrhythmia and mortality among LCFAODs. Until recently, only 68 cases of CACTD had been reported in the literature. This number increased to 87 with a recent publication by…
Meeting Coverage
- Loading...
Loading...
Recent Quizzes- Test Your Knowledge About the Complications of NMOSD January 13, 2022
- Test Your Knowledge About Testing in Alagille Syndrome January 7, 2022
- Test Your Knowledge About the Experimental Therapies for CAD December 8, 2021
- Test Your Knowledge About the Complications of Alagille Syndrome December 2, 2021
- Test Your Knowledge About the Etiology of LAL-D November 25, 2021
- Test Your Knowledge About the Types of Alagille Syndrome November 4, 2021
- Test Your Knowledge About the Symptoms of Patients With AATD October 7, 2021
- Test Your Knowledge About the Differential Diagnosis of Patients With LCFAOD October 6, 2021
Loading... 
Loading...